[go: up one dir, main page]

MX2008002066A - Neuva forma cristalina de perindopril-erbumina. - Google Patents

Neuva forma cristalina de perindopril-erbumina.

Info

Publication number
MX2008002066A
MX2008002066A MX2008002066A MX2008002066A MX2008002066A MX 2008002066 A MX2008002066 A MX 2008002066A MX 2008002066 A MX2008002066 A MX 2008002066A MX 2008002066 A MX2008002066 A MX 2008002066A MX 2008002066 A MX2008002066 A MX 2008002066A
Authority
MX
Mexico
Prior art keywords
crystalline form
new crystalline
perindopril erbumine
perindopril
erbumine
Prior art date
Application number
MX2008002066A
Other languages
English (en)
Spanish (es)
Inventor
Ulrich Griesser
Verena Niederwanger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of MX2008002066A publication Critical patent/MX2008002066A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
MX2008002066A 2005-08-12 2006-08-10 Neuva forma cristalina de perindopril-erbumina. MX2008002066A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200500231 2005-08-12
PCT/EP2006/007923 WO2007020009A1 (fr) 2005-08-12 2006-08-10 Nouvelle forme cristalline de perindopril erbumine

Publications (1)

Publication Number Publication Date
MX2008002066A true MX2008002066A (es) 2008-04-16

Family

ID=37478710

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008002066A MX2008002066A (es) 2005-08-12 2006-08-10 Neuva forma cristalina de perindopril-erbumina.

Country Status (10)

Country Link
US (1) US20090099370A1 (fr)
EP (1) EP1942886A1 (fr)
JP (1) JP2009505970A (fr)
CN (1) CN101227902A (fr)
AU (1) AU2006281681A1 (fr)
CA (1) CA2618516A1 (fr)
EA (1) EA200800411A1 (fr)
MX (1) MX2008002066A (fr)
WO (1) WO2007020009A1 (fr)
ZA (1) ZA200800432B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0614622A2 (pt) * 2005-08-12 2011-04-12 Lek Pharmaceuticals processo para a preparação de perindopril erbumina
AU2013201812B2 (en) * 2007-06-27 2015-04-02 Les Laboratoires Servier Salts of perindopril
SI22543A (sl) * 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
PT105315B (pt) 2010-09-29 2013-01-16 Inst Superior Tecnico Uma nova forma cristalina hidratada de erbumina de perindopril, métodos para a sua preparação e sua utilização em preparações farmacêuticas
FR2985511B1 (fr) * 2012-01-05 2014-01-03 Servier Lab Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
WO2016178591A2 (fr) 2015-05-05 2016-11-10 Gene Predit, Sa Marqueurs génétiques et traitement de l'obésité masculine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
BRPI0411966A (pt) * 2003-06-24 2006-08-29 Servier Lab formas cristalinas de perindopril erbumina
AU2003300689B2 (en) * 2003-10-21 2009-01-29 Les Laboratoires Servier Novel method for preparation of crystalline perindopril erbumine
PL1861367T3 (pl) * 2005-03-14 2009-12-31 Servier Lab Ulepszony sposób oczyszczania Perindoprylu
AU2006278866B2 (en) * 2005-07-25 2012-03-15 Lek Pharmaceuticals D.D. Process for the preparation of crystalline perindopril

Also Published As

Publication number Publication date
ZA200800432B (en) 2008-12-31
AU2006281681A1 (en) 2007-02-22
CN101227902A (zh) 2008-07-23
US20090099370A1 (en) 2009-04-16
WO2007020009A1 (fr) 2007-02-22
CA2618516A1 (fr) 2007-02-22
EA200800411A1 (ru) 2008-08-29
EP1942886A1 (fr) 2008-07-16
JP2009505970A (ja) 2009-02-12

Similar Documents

Publication Publication Date Title
MX2010006738A (es) Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos.
MX2010006736A (es) Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos.
MY148253A (en) Azaadamantane derivatives and methods of use
NZ592897A (en) Crystals of laquinimod sodium, and process for the manufacture thereof
EP2194043A3 (fr) Procédés et intermédiaires
GEP20104974B (en) Carbonylamino pyrrolopyrazoles, protent kinase inhibitors
PL1682530T3 (pl) Podstawione pirolo-indole jako inhibitory PAI-1
MX2007005221A (es) Formas cristalinas de ascomicina y preparacion de ellas.
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
MX2009003834A (es) Derivados de pirrolidina como inhibidores de iap.
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
IL187453A0 (en) The preparation and uses of compounds as aspartyl protease inhibitors
TW200716525A (en) Process for preparation of sulfamide derivatives
NO20065046L (no) Krystallinsk polymorf av bazedoksifenacetat
WO2006069719A3 (fr) Lyophilisation de virosomes
ZA200800432B (en) New crystalline form of perindopril erbumine
MX2009000198A (es) Formas cristalinas de profarmaco amida de gemcitabina, composiciones y usos del mismo.
MY136938A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
ZA200800138B (en) Process for the preparation of crystalline perindopril
TW200800986A (en) Tetrahydroquinolines, synthesis thereof, and intermediates thereto
NO20060535L (no) Aztreonam-L-lysin og fremgangsmater for fremstilling av dette
TW200738713A (en) Diazepinoquinolines, synthesis thereof, and intermediates thereto
MX2007011826A (es) Composiciones farmaceuticas de liberacion controlada de liotironina y metodos para elaborar y utilizar las mismas.
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
MY136288A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts

Legal Events

Date Code Title Description
FA Abandonment or withdrawal